Form 4: Inspire Medical Systems Executive Randy Ban Reports Stock Transactions

Randy Ban, an executive at Inspire Medical Systems, reported the acquisition and disposal of company stock related to vesting performance stock units.

Summary

• On February 24, 2025, Randy Ban, Executive Vice President at Inspire Medical Systems, reported transactions involving the company's common stock.
• Ban acquired 6,152 shares of common stock due to the vesting of previously granted performance stock units.
• 2,205 shares were withheld by the issuer to cover taxes related to the vesting of the performance stock unit award at a price of $186.45.
• Following these transactions, Ban directly owns 11,206 shares of common stock.
• Ban also indirectly owns 167 shares held by his son and 166 shares held by his daughter.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The vesting of performance stock units suggests that performance goals were met, which is a positive indicator.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices involving stock-based awards.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to align the interests of executives with those of shareholders.
• Vesting schedules and performance-based equity awards are frequently used to incentivize long-term value creation.
• Tax withholding on vesting equity is a standard procedure.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation.

Key Dates